S

    Shuttle Pharmaceuticals Inc (SHPH)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $3.36
    -0.18 (-5.08%)

    Market Cap: $1.97M

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    Reported Aug 11
    		$-32.90N/AN/ABeat-900.0%
    Mar 26
    Reported Apr 1
    		$-4.28N/AN/ABeat+43.7%
    Dec 25
    Reported Dec 31
    		$-12.92N/AN/ABeat-3130.5%
    Sep 25
    Reported Nov 13
    		$-1.05N/AN/ABeat+99.7%
    Jun 25
    Reported Aug 12
    		$-3.29N/AN/ABeat+98.6%
    Mar 25
    Reported May 8
    		$-7.60N/AN/ABeat+96.4%
    Dec 24
    Reported Mar 20
    		$-0.40N/AN/ABeat+99.8%
    Sep 24
    Reported Nov 13
    		$-396.79N/AN/ABeat-74.2%
    Jun 24
    Reported Sep 3
    		$-241.24N/AN/ABeat+21.2%
    Mar 24
    Reported May 13
    		$-208.48N/AN/ABeat-45.8%
    Dec 23
    Reported Mar 21
    		$-204.18N/AN/ABeat-340192.5%
    Sep 23
    Reported Nov 13
    		$-227.74N/AN/ABeat-1138575.0%
    Jun 23
    Reported Aug 14
    		$-306.34N/AN/ABeat-612570.6%
    Mar 23
    Reported May 25
    		$-143.02N/AN/ABeat-
    Dec 22
    Reported Mar 15
    		$-0.06N/AN/ABeat-
    Sep 22
    Reported Nov 14
    		$-0.02N/AN/ABeat-
    Jun 22
    Reported Jul 13
    		$-0.05$0.00N/AMiss-400.0%
    Sep 17
    Reported Nov 20
    		$0.00$0.00N/ABeat-
    Jun 17
    Reported Aug 14
    		$0.00$0.00N/ABeat-
    Mar 17
    Reported Jun 26
    		$0.00$0.00N/ABeat-
    Sep 16
    Reported Dec 9
    		$-0.01$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-0.07EV/EBITDA-0.67x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-326.40%ROIC-112.59%
    Financial Health
    Debt/Equity1.33xInterest Coverage40.83x
    Current Ratio0.30xQuick Ratio0.30x
    Trading Statistics
    Beta1.22Avg Volume146.67K
    52-Week High$55.9052-Week Low$2.58

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$3.65
    SMA 20$3.94
    SMA 50$3.58
    SMA 200$9.93
    EMA 10$3.66
    EMA 20$3.72
    EMA 50$4.05
    EMA 200$14.60

    MACD

    Line: -0.06Signal: 0.01Hist: -0.06

    ADX

    ADX: 32.9+DI: 26.4-DI: 18.3

    Aroon & PSAR

    Aroon Up52.0
    Aroon Down8.0
    PSAR$3.05

    Bollinger Bands

    Upper Band$4.70
    Lower Band$3.18
    %B Position3859%(Upper)
    Band Width0.12

    RSI (14-Day)

    Neutral
    43.6

    Momentum Oscillators

    Stoch %K20.1
    Stoch %D22.7
    Williams %R-95.4
    ROC (10d)-18.0%
    Momentum-0.74
    CCI (20d)-107.6
    MFI (14d)67.9

    Volatility Measures

    ATR (14d)$0.48(14.2%)
    StdDev (20d)0.38
    Hist Vol132.1%(High)

    Volume Flow

    VWAP$3.45
    OBV28.7M
    AD Line670.8B
    CMF (20d)0.651

    Volume Metrics

    Avg Vol (20d)144.8K
    Vol Ratio0.4x(Low)
    VWMA (20d)$4.26

    Pivot Points

    R3$3.93
    R2$3.83
    R1$3.69
    Pivot Point$3.59
    S1$3.45
    S2$3.35
    S3$3.21

    Advanced Oscillators

    TSI-2.88
    Ultimate Osc39.4
    KST107.68

    Financial Data

    QuarterMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Total Revenue$0$0$0$0$0$5,748$0$0$0$9,656$0$0
    Cost of Revenue$0$289,070$0$0$0$1,796$0$0$0$1,983$0$0
    Gross Profit$0$-289,070$0$0$0$-1,796$0$0$0$-1,983$0$0
    Operating Expenses$2.22M$2.79M$2.27M$3.91M$2.95M$1.78M$3.05M$1.48M$1.38M$1.28M$1.60M$1.47M
    R&D$267,240$511,878$943,478$1.03M$1.57M$986,409$1.40M$645,719$586,104$710,450$1.05M$839,665
    SG&A$1.16M$1.84M$886,055$2.35M$596,886$429,067$328,995$310,038$324,609$316,667$265,553$209,279
    Operating Income$-2,216,822$-2,788,235$-2,266,942$-3,910,406$-2,951,241$-1,777,128$-3,051,561$-1,482,634$-1,384,847$-1,282,824$-1,599,146$-1,465,632
    Interest Income$209$523$486$81$0$-71,565$58,922$53,841$25,490$25,623$20,765$21,011
    Interest Expense$12,122$-324,399$18,904$21,743$11,930$6,555$272,675$430,685$497,515$532,046$623,465$731,939
    Income Before Tax$-2,152,471$-2,611,544$-2,347,302$-3,706,465$-3,053,007$-1,598,469$-3,784,082$-2,031,215$-1,731,031$-1,640,500$-1,792,754$-2,184,372
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-2,152,471$-2,614,895$-2,347,302$-3,706,465$-3,053,007$-1,598,469$-3,784,082$-2,031,215$-1,731,031$-1,640,500$-1,792,754$-2,184,372
    EBITDA$-1,495,096$-2,633,475$-2,309,694$-3,662,390$-3,033,534$-1,518,553$-3,322,106$-1,266,904$-811,585$-663,769$-649,894$-922,837
    EBIT$-2,140,558$-2,936,466$-2,328,884$-3,684,803$-3,041,077$-1,520,349$-3,570,329$-1,654,371$-1,259,006$-1,134,077$-1,190,054$-1,473,444
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about SHPH

    News

    Shuttle Pharmaceuticals Receives Nasdaq Noncompliance Notice Over 10-Q

    Shuttle Pharmaceuticals Holdings, Inc. (SHPH) received a Nasdaq noncompliance notice because it failed to file its Form 10-Q for the quarter ended June 30, 2026. The company must submit a remediation plan by October 27, 2026, to avoid potential delisting. While the notice does not immediately affect trading, sustained noncompliance could lead to delisting.

    TipRanks•8/28/26•
    Bearish

    Shuttle Pharma (NASDAQ: SHPH) rethinks Dogecoin merger accounting

    Shuttle Pharmaceuticals Holdings, Inc. (SHPH) has amended its prior merger report concerning United Dogecoin Inc. (UDC), reclassifying the transaction. SHPH determined that UDC does not meet the definition of a business under ASC 805, as it lacked revenue-generating operations, material assets, or an organized workforce at the time of the merger. Consequently, the merger will not be accounted for as a business combination, and historical and pro forma financial statements for UDC are not required.

    Stock Titan•8/18/26•
    Neutral

    Shuttle Pharma (SHPH) slashes R&D 95% as Dogecoin legal bills climb

    Shuttle Pharmaceuticals Holdings, Inc. (SHPH) has delayed its Q2 2026 report due to difficulties in compiling required disclosure information. Preliminary data reveals a 95% cut in R&D expenses to $0.1 million and a 112% increase in legal and professional expenses, primarily due to its merger with United Dogecoin Inc. The company expects to file its quarterly report within the five-day grace period.

    Stock Titan•8/18/26•
    Bearish

    Shuttle Pharmaceuticals Holdings Inc (SHPH) Earnings Forecast: Future EPS & Revenue Growth Estimates

    This article provides a brief overview of Shuttle Pharmaceuticals Holdings Inc. (SHPH), focusing on its earnings forecast and current stock data. It indicates the stock's performance, market capitalization, and P/E TTM, and mentions sections available for financial forecasting. The content is primarily a data placeholder from TradingKey.

    TradingKey•8/8/26•
    Neutral

    Shuttle Pharmaceuticals announces special shareholder meeting

    Shuttle Pharmaceuticals will hold a virtual special shareholder meeting on September 3, 2026, for shareholders to vote on several key proposals. These include share issuances related to the United Dogecoin acquisition and a new financing, as well as expanding the 2018 Equity Incentive Plan and a proposed corporate name change to United Compute. The content of this news brief was generated by Public Technologies using AI, based on original content from Shuttle Pharmaceuticals Holdings Inc. via EDGAR.

    Bitget•8/3/26•
    Neutral

    Frequently Asked Questions About SHPH

    Does SHPH pay dividends?
    Shuttle Pharmaceuticals Inc (SHPH) does not currently pay a regular dividend.
    What is SHPH's market cap?
    Shuttle Pharmaceuticals Inc (SHPH) has a market capitalization of $1.97M with a current stock price of $3.36.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In